http://www.pharmaceutical-technology.com/news/fabre-kramer-depressive-disorder-therapy/
0
0
9/29/23 at 7:06am
Organization
Pharmaceutical Technology
Author
RanjithKumar Dharma
30 words
0
Comments
Fabre-Kramer has obtained approval from the US FDA for Exxua to treat major depressive disorder (MDD) in adult patients.
You are the first to view
Create an account
or login to join the discussion